25 XP   0   0   10

Windlas Biotech Limited
Buy, Hold or Sell?

Let's analyse Windlas together

PenkeI guess you are interested in Windlas Biotech Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Windlas Biotech Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Windlas Biotech Limited

I send you an email if I find something interesting about Windlas Biotech Limited.

Quick analysis of Windlas (30 sec.)










What can you expect buying and holding a share of Windlas? (30 sec.)

How much money do you get?

How much money do you get?
INR0.17
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
INR185.93
Expected worth in 1 year
INR170.40
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
INR-1.43
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
INR551.20
Expected price per share
INR460.55 - INR590.85
How sure are you?
50%

1. Valuation of Windlas (5 min.)




Live pricePrice per Share (EOD)

INR551.20

Intrinsic Value Per Share

INR-49.26 - INR-59.15

Total Value Per Share

INR136.66 - INR126.78

2. Growth of Windlas (5 min.)




Is Windlas growing?

Current yearPrevious yearGrowGrow %
How rich?$48.2m$47.3m$899.2k1.9%

How much money is Windlas making?

Current yearPrevious yearGrowGrow %
Making money$5.1m$4.5m$544.4k10.6%
Net Profit Margin8.3%8.2%--

How much money comes from the company's main activities?

3. Financial Health of Windlas (5 min.)




What can you expect buying and holding a share of Windlas? (5 min.)

Welcome investor! Windlas's management wants to use your money to grow the business. In return you get a share of Windlas.

What can you expect buying and holding a share of Windlas?

First you should know what it really means to hold a share of Windlas. And how you can make/lose money.

Speculation

The Price per Share of Windlas is INR551.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Windlas.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Windlas, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR185.93. Based on the TTM, the Book Value Change Per Share is INR-3.88 per quarter. Based on the YOY, the Book Value Change Per Share is INR94.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR3.53 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Windlas.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.240.0%0.240.0%0.220.0%0.200.0%0.200.0%
Usd Book Value Change Per Share-0.050.0%-0.050.0%1.130.2%0.450.1%0.450.1%
Usd Dividend Per Share0.040.0%0.040.0%0.040.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.000.0%0.000.0%1.170.2%0.460.1%0.460.1%
Usd Price Per Share2.70-2.70-2.52-1.04-1.04-
Price to Earnings Ratio11.44-11.44-11.47-4.58-4.58-
Price-to-Total Gains Ratio-632.14--632.14-2.15--315.00--315.00-
Price to Book Ratio1.21-1.21-1.11-0.46-0.46-
Price-to-Total Gains Ratio-632.14--632.14-2.15--315.00--315.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.6144
Number of shares151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share-0.050.45
Usd Total Gains Per Share0.000.46
Gains per Quarter (151 shares)-0.6569.99
Gains per Year (151 shares)-2.58279.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126-28-1310270270
251-56-1621539550
377-84-1931809830
4102-113-224210781110
5128-141-255213481390
6153-169-286316171670
7179-197-317318871950
8204-225-348321562230
9230-253-379424262510
10256-281-4010426952790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%2.00.03.040.0%2.00.03.040.0%2.00.03.040.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%

Fundamentals of Windlas

About Windlas Biotech Limited

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2024-04-09 11:58:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Windlas Biotech Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Windlas earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.3% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Windlas Biotech Limited:

  • The MRQ is 8.3%. The company is making a profit. +1
  • The TTM is 8.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.3%TTM8.3%0.0%
TTM8.3%YOY8.2%+0.1%
TTM8.3%5Y9.2%-0.9%
5Y9.2%10Y9.2%0.0%
1.1.2. Return on Assets

Shows how efficient Windlas is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.1% Return on Assets means that Windlas generated ₹0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Windlas Biotech Limited:

  • The MRQ is 8.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.1%TTM8.1%0.0%
TTM8.1%YOY7.8%+0.3%
TTM8.1%5Y9.5%-1.4%
5Y9.5%10Y9.5%0.0%
1.1.3. Return on Equity

Shows how efficient Windlas is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.6% Return on Equity means Windlas generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Windlas Biotech Limited:

  • The MRQ is 10.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY9.6%+0.9%
TTM10.6%5Y13.8%-3.2%
5Y13.8%10Y13.8%0.0%

1.2. Operating Efficiency of Windlas Biotech Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Windlas is operating .

  • Measures how much profit Windlas makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 11.3% means the company generated ₹0.11  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Windlas Biotech Limited:

  • The MRQ is 11.3%. The company is operating less efficient.
  • The TTM is 11.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM11.3%0.0%
TTM11.3%YOY9.8%+1.5%
TTM11.3%5Y8.7%+2.6%
5Y8.7%10Y8.7%0.0%
1.2.2. Operating Ratio

Measures how efficient Windlas is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.91 means that the operating costs are ₹0.91 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Windlas Biotech Limited:

  • The MRQ is 0.907. The company is less efficient in keeping operating costs low.
  • The TTM is 0.907. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.907TTM0.9070.000
TTM0.907YOY0.912-0.006
TTM0.9075Y0.903+0.003
5Y0.90310Y0.9030.000

1.3. Liquidity of Windlas Biotech Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Windlas is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.92 means the company has ₹2.92 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Windlas Biotech Limited:

  • The MRQ is 2.916. The company is able to pay all its short-term debts. +1
  • The TTM is 2.916. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.916TTM2.9160.000
TTM2.916YOY4.061-1.145
TTM2.9165Y2.330+0.586
5Y2.33010Y2.3300.000
1.3.2. Quick Ratio

Measures if Windlas is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.13 means the company can pay off ₹3.13 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Windlas Biotech Limited:

  • The MRQ is 3.135. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.135. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.135TTM3.1350.000
TTM3.135YOY5.303-2.168
TTM3.1355Y2.541+0.594
5Y2.54110Y2.5410.000

1.4. Solvency of Windlas Biotech Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Windlas assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Windlas to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.24 means that Windlas assets are financed with 24.0% credit (debt) and the remaining percentage (100% - 24.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Windlas Biotech Limited:

  • The MRQ is 0.240. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.240. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.240TTM0.2400.000
TTM0.240YOY0.196+0.044
TTM0.2405Y0.299-0.059
5Y0.29910Y0.2990.000
1.4.2. Debt to Equity Ratio

Measures if Windlas is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 31.5% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Windlas Biotech Limited:

  • The MRQ is 0.315. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.315. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.315TTM0.3150.000
TTM0.315YOY0.244+0.071
TTM0.3155Y0.440-0.125
5Y0.44010Y0.4400.000

2. Market Valuation of Windlas Biotech Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Windlas generates.

  • Above 15 is considered overpriced but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.44 means the investor is paying ₹11.44 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Windlas Biotech Limited:

  • The EOD is 27.978. Based on the earnings, the company is overpriced. -1
  • The MRQ is 11.436. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.436. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD27.978MRQ11.436+16.542
MRQ11.436TTM11.4360.000
TTM11.436YOY11.470-0.034
TTM11.4365Y4.581+6.855
5Y4.58110Y4.5810.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Windlas Biotech Limited:

  • The EOD is -120.158. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -49.114. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -49.114. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-120.158MRQ-49.114-71.044
MRQ-49.114TTM-49.1140.000
TTM-49.114YOY-76.996+27.882
TTM-49.1145Y-25.222-23.892
5Y-25.22210Y-25.2220.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Windlas is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.21 means the investor is paying ₹1.21 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Windlas Biotech Limited:

  • The EOD is 2.965. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.212. Based on the equity, the company is underpriced. +1
  • The TTM is 1.212. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.965MRQ1.212+1.753
MRQ1.212TTM1.2120.000
TTM1.212YOY1.107+0.105
TTM1.2125Y0.464+0.748
5Y0.46410Y0.4640.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Windlas Biotech Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.882-3.8820%94.073-104%37.185-110%37.185-110%
Book Value Per Share--185.927185.9270%189.809-2%132.220+41%132.220+41%
Current Ratio--2.9162.9160%4.061-28%2.330+25%2.330+25%
Debt To Asset Ratio--0.2400.2400%0.196+22%0.299-20%0.299-20%
Debt To Equity Ratio--0.3150.3150%0.244+29%0.440-28%0.440-28%
Dividend Per Share--3.5263.5260%3.668-4%1.439+145%1.439+145%
Eps--19.70119.7010%18.313+8%16.541+19%16.541+19%
Free Cash Flow Per Share---4.587-4.5870%-2.728-41%0.899-610%0.899-610%
Free Cash Flow To Equity Per Share---24.803-24.8030%59.818-141%8.345-397%8.345-397%
Gross Profit Margin--0.6570.6570%0.720-9%0.644+2%0.644+2%
Intrinsic Value_10Y_max---59.148--------
Intrinsic Value_10Y_min---49.263--------
Intrinsic Value_1Y_max---2.491--------
Intrinsic Value_1Y_min---2.421--------
Intrinsic Value_3Y_max---10.104--------
Intrinsic Value_3Y_min---9.495--------
Intrinsic Value_5Y_max---20.873--------
Intrinsic Value_5Y_min---18.951--------
Market Cap11464188320.000+57%4874572776.0004874572776.0000%4368745930.000+12%1848663741.200+164%1848663741.200+164%
Net Profit Margin--0.0830.0830%0.082+1%0.092-10%0.092-10%
Operating Margin--0.1130.1130%0.098+15%0.087+30%0.087+30%
Operating Ratio--0.9070.9070%0.912-1%0.903+0%0.903+0%
Pb Ratio2.965+59%1.2121.2120%1.107+9%0.464+161%0.464+161%
Pe Ratio27.978+59%11.43611.4360%11.4700%4.581+150%4.581+150%
Price Per Share551.200+59%225.300225.3000%210.050+7%87.070+159%87.070+159%
Price To Free Cash Flow Ratio-120.158-145%-49.114-49.1140%-76.996+57%-25.222-49%-25.222-49%
Price To Total Gains Ratio-1546.542-145%-632.141-632.1410%2.149-29515%-314.996-50%-314.996-50%
Quick Ratio--3.1353.1350%5.303-41%2.541+23%2.541+23%
Return On Assets--0.0810.0810%0.078+4%0.095-15%0.095-15%
Return On Equity--0.1060.1060%0.096+10%0.138-23%0.138-23%
Total Gains Per Share---0.356-0.3560%97.740-100%38.624-101%38.624-101%
Usd Book Value--48272520.00048272520.0000%47373240.000+2%33585864.000+44%33585864.000+44%
Usd Book Value Change Per Share---0.047-0.0470%1.129-104%0.446-110%0.446-110%
Usd Book Value Per Share--2.2312.2310%2.278-2%1.587+41%1.587+41%
Usd Dividend Per Share--0.0420.0420%0.044-4%0.017+145%0.017+145%
Usd Eps--0.2360.2360%0.220+8%0.198+19%0.198+19%
Usd Free Cash Flow---1191000.000-1191000.0000%-680880.000-43%225696.000-628%225696.000-628%
Usd Free Cash Flow Per Share---0.055-0.0550%-0.033-41%0.011-610%0.011-610%
Usd Free Cash Flow To Equity Per Share---0.298-0.2980%0.718-141%0.100-397%0.100-397%
Usd Market Cap137570259.840+57%58494873.31258494873.3120%52424951.160+12%22183964.894+164%22183964.894+164%
Usd Price Per Share6.614+59%2.7042.7040%2.521+7%1.045+159%1.045+159%
Usd Profit--5115120.0005115120.0000%4570680.000+12%4237968.000+21%4237968.000+21%
Usd Revenue--61569960.00061569960.0000%55604760.000+11%48884592.000+26%48884592.000+26%
Usd Total Gains Per Share---0.004-0.0040%1.173-100%0.463-101%0.463-101%
 EOD+4 -4MRQTTM+0 -0YOY+14 -225Y+19 -1710Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Windlas Biotech Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.978
Price to Book Ratio (EOD)Between0-12.965
Net Profit Margin (MRQ)Greater than00.083
Operating Margin (MRQ)Greater than00.113
Quick Ratio (MRQ)Greater than13.135
Current Ratio (MRQ)Greater than12.916
Debt to Asset Ratio (MRQ)Less than10.240
Debt to Equity Ratio (MRQ)Less than10.315
Return on Equity (MRQ)Greater than0.150.106
Return on Assets (MRQ)Greater than0.050.081
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Windlas Biotech Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.659
Ma 20Greater thanMa 50539.103
Ma 50Greater thanMa 100527.995
Ma 100Greater thanMa 200491.314
OpenGreater thanClose563.000
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,289,750
Total Liabilities1,267,040
Total Stockholder Equity4,022,710
 As reported
Total Liabilities 1,267,040
Total Stockholder Equity+ 4,022,710
Total Assets = 5,289,750

Assets

Total Assets5,289,750
Total Current Assets3,535,360
Long-term Assets1,754,390
Total Current Assets
Cash And Cash Equivalents 36,860
Short-term Investments 1,297,500
Net Receivables 1,168,600
Inventory 747,380
Other Current Assets 285,020
Total Current Assets  (as reported)3,535,360
Total Current Assets  (calculated)3,535,360
+/-0
Long-term Assets
Property Plant Equipment 1,227,010
Intangible Assets 14,840
Long-term Assets Other 434,110
Long-term Assets  (as reported)1,754,390
Long-term Assets  (calculated)1,675,960
+/- 78,430

Liabilities & Shareholders' Equity

Total Current Liabilities1,212,420
Long-term Liabilities54,620
Total Stockholder Equity4,022,710
Total Current Liabilities
Short-term Debt 18,670
Short Long Term Debt 3,350
Accounts payable 877,430
Other Current Liabilities 41,460
Total Current Liabilities  (as reported)1,212,420
Total Current Liabilities  (calculated)940,910
+/- 271,510
Long-term Liabilities
Long term Debt 1,090
Capital Lease Obligations 45,490
Long-term Liabilities  (as reported)54,620
Long-term Liabilities  (calculated)46,580
+/- 8,040
Total Stockholder Equity
Common Stock104,630
Retained Earnings 1,763,460
Accumulated Other Comprehensive Income 168,440
Other Stockholders Equity 1,986,180
Total Stockholder Equity (as reported)4,022,710
Total Stockholder Equity (calculated)4,022,710
+/-0
Other
Capital Stock104,630
Cash and Short Term Investments 1,334,360
Common Stock Shares Outstanding 21,636
Current Deferred Revenue274,860
Liabilities and Stockholders Equity 5,289,750
Net Debt 13,070
Net Invested Capital 4,027,150
Net Working Capital 2,322,940
Property Plant and Equipment Gross 1,227,010
Short Long Term Debt Total 49,930



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-31
> Total Assets 
0
2,981,800
3,384,880
2,961,230
4,910,110
5,289,750
5,289,7504,910,1102,961,2303,384,8802,981,8000
   > Total Current Assets 
1,439,520
1,204,600
1,680,290
1,943,110
3,816,510
3,535,360
3,535,3603,816,5101,943,1101,680,2901,204,6001,439,520
       Cash And Cash Equivalents 
0
128,550
180,780
159,300
5,700
36,860
36,8605,700159,300180,780128,5500
       Short-term Investments 
0
212,410
225,860
383,250
1,754,560
1,297,500
1,297,5001,754,560383,250225,860212,4100
       Net Receivables 
665,910
617,860
640,330
973,210
1,469,160
1,168,600
1,168,6001,469,160973,210640,330617,860665,910
       Inventory 
350,540
190,270
493,170
414,610
587,100
747,380
747,380587,100414,610493,170190,270350,540
       Other Current Assets 
117,400
673,370
780,480
12,740
-10
285,020
285,020-1012,740780,480673,370117,400
   > Long-term Assets 
0
1,777,200
1,704,590
1,018,120
1,093,600
1,754,390
1,754,3901,093,6001,018,1201,704,5901,777,2000
       Property Plant Equipment 
935,590
704,520
700,640
956,680
984,680
1,227,010
1,227,010984,680956,680700,640704,520935,590
       Intangible Assets 
0
4,420
5,520
4,820
8,810
14,840
14,8408,8104,8205,5204,4200
       Long-term Assets Other 
0
259,240
51,790
-508,100
54,150
434,110
434,11054,150-508,10051,790259,2400
> Total Liabilities 
0
1,045,950
1,288,290
970,040
962,340
1,267,040
1,267,040962,340970,0401,288,2901,045,9500
   > Total Current Liabilities 
1,430,900
962,170
1,252,890
934,190
939,860
1,212,420
1,212,420939,860934,1901,252,890962,1701,430,900
       Short-term Debt 
0
245,250
266,880
310,000
61,930
18,670
18,67061,930310,000266,880245,2500
       Short Long Term Debt 
0
240,960
262,180
304,840
56,770
3,350
3,35056,770304,840262,180240,9600
       Accounts payable 
846,170
579,340
831,360
399,330
632,320
877,430
877,430632,320399,330831,360579,340846,170
       Other Current Liabilities 
138,340
137,580
421,530
534,860
15,040
41,460
41,46015,040534,860421,530137,580138,340
   > Long-term Liabilities 
0
83,780
35,400
35,850
22,480
54,620
54,62022,48035,85035,40083,7800
       Capital Lease Obligations Min Short Term Debt
0
-225,910
-251,850
-299,670
-56,770
26,820
26,820-56,770-299,670-251,850-225,9100
       Long-term Liabilities Other 
0
0
0
0
40
0
0400000
> Total Stockholder Equity
0
1,935,850
2,096,590
1,991,190
3,947,770
4,022,710
4,022,7103,947,7701,991,1902,096,5901,935,8500
   Common Stock
55,880
64,110
64,110
64,110
108,970
104,630
104,630108,97064,11064,11064,11055,880
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 
0
0
136,250
136,220
154,320
168,440
168,440154,320136,220136,25000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
2,850
891,160
754,910
754,910
2,269,470
1,986,180
1,986,1802,269,470754,910754,910891,1602,850



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue5,130,830
Cost of Revenue-3,254,470
Gross Profit1,876,3601,876,360
 
Operating Income (+$)
Gross Profit1,876,360
Operating Expense-1,397,740
Operating Income478,700478,620
 
Operating Expense (+$)
Research Development89,480
Selling General Administrative40,120
Selling And Marketing Expenses146,000
Operating Expense1,397,740275,600
 
Net Interest Income (+$)
Interest Income34,900
Interest Expense-7,880
Other Finance Cost-34,900
Net Interest Income-7,880
 
Pretax Income (+$)
Operating Income478,700
Net Interest Income-7,880
Other Non-Operating Income Expenses0
Income Before Tax (EBT)570,390387,010
EBIT - interestExpense = 570,390
570,390
434,140
Interest Expense7,880
Earnings Before Interest and Taxes (EBIT)578,270578,270
Earnings Before Interest and Taxes (EBITDA)701,910
 
After tax Income (+$)
Income Before Tax570,390
Tax Provision-144,130
Net Income From Continuing Ops426,260426,260
Net Income426,260
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,652,210
Total Other Income/Expenses Net91,6907,880
 

Technical Analysis of Windlas
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Windlas. The general trend of Windlas is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Windlas's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Windlas Biotech Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 568.95 < 590.85.

The bearish price targets are: 485.00 > 474.10 > 460.55.

Tweet this
Windlas Biotech Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Windlas Biotech Limited. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Windlas Biotech Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Windlas Biotech Limited. The current macd is 6.69119169.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Windlas price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Windlas. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Windlas price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Windlas Biotech Limited Daily Moving Average Convergence/Divergence (MACD) ChartWindlas Biotech Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Windlas Biotech Limited. The current adx is 12.88.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Windlas shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Windlas Biotech Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Windlas Biotech Limited. The current sar is 496.44.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Windlas Biotech Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Windlas Biotech Limited. The current rsi is 54.66. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Windlas Biotech Limited Daily Relative Strength Index (RSI) ChartWindlas Biotech Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Windlas Biotech Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Windlas price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Windlas Biotech Limited Daily Stochastic Oscillator ChartWindlas Biotech Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Windlas Biotech Limited. The current cci is 94.59.

Windlas Biotech Limited Daily Commodity Channel Index (CCI) ChartWindlas Biotech Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Windlas Biotech Limited. The current cmo is 10.21.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Windlas Biotech Limited Daily Chande Momentum Oscillator (CMO) ChartWindlas Biotech Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Windlas Biotech Limited. The current willr is -38.37129055.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Windlas is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Windlas Biotech Limited Daily Williams %R ChartWindlas Biotech Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Windlas Biotech Limited.

Windlas Biotech Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Windlas Biotech Limited. The current atr is 26.39.

Windlas Biotech Limited Daily Average True Range (ATR) ChartWindlas Biotech Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Windlas Biotech Limited. The current obv is 12,521,722.

Windlas Biotech Limited Daily On-Balance Volume (OBV) ChartWindlas Biotech Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Windlas Biotech Limited. The current mfi is 53.61.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Windlas Biotech Limited Daily Money Flow Index (MFI) ChartWindlas Biotech Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Windlas Biotech Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Windlas Biotech Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Windlas Biotech Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.659
Ma 20Greater thanMa 50539.103
Ma 50Greater thanMa 100527.995
Ma 100Greater thanMa 200491.314
OpenGreater thanClose563.000
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Windlas with someone you think should read this too:
  • Are you bullish or bearish on Windlas? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Windlas? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Windlas Biotech Limited

I send you an email if I find something interesting about Windlas Biotech Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Windlas Biotech Limited.

Receive notifications about Windlas Biotech Limited in your mailbox!